These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 34230225)

  • 1. High Levels of IL-8 and MCP-1 in Cerebrospinal Fluid of COVID-19 Patients with Cerebrovascular Disease.
    Guartazaca-Guerrero S; Rodríguez-Morales J; Rizo-Téllez SA; Solleiro-Villavicencio H; Hernández-Valencia AF; Carrillo-Ruiz JD; Escobedo G; Méndez-García LA
    Exp Neurobiol; 2021 Jun; 30(3):256-261. PubMed ID: 34230225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients.
    Normandin E; Holroyd KB; Collens SI; Shaw BM; Siddle KJ; Adams G; Rudy M; Solomon IH; Anahtar MN; Lemieux JE; Trombetta BA; Kivisakk P; Arnold SE; Rapalino O; Piantadosi AL; Sen P; Rosenberg ES; Branda J; Sabeti PC; Mukerji SS
    J Neurol Sci; 2021 Nov; 430():120023. PubMed ID: 34678659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis.
    Devlin L; Gombolay GY
    J Neurol; 2023 Nov; 270(11):5155-5161. PubMed ID: 37581633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
    Chi Y; Ge Y; Wu B; Zhang W; Wu T; Wen T; Liu J; Guo X; Huang C; Jiao Y; Zhu F; Zhu B; Cui L
    J Infect Dis; 2020 Aug; 222(5):746-754. PubMed ID: 32563194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain Barrier Damage is Pivotal for SARS-CoV-2 Infection to the Central Nervous System.
    Rodríguez-Morales J; Guartazaca-Guerrero S; Rizo-Téllez SA; Viurcos-Sanabria R; Barrón EV; Hernández-Valencia AF; Nava P; Escobedo G; Carrillo-Ruiz JD; Méndez-García LA
    Exp Neurobiol; 2022 Aug; 31(4):270-276. PubMed ID: 36050226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
    Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
    mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
    Baig AM
    ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid in COVID-19 neurological complications: no cytokine storm or neuroinflammation.
    Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; Pardo CA
    medRxiv; 2021 Jan; ():. PubMed ID: 33469596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke.
    Al Saiegh F; Ghosh R; Leibold A; Avery MB; Schmidt RF; Theofanis T; Mouchtouris N; Philipp L; Peiper SC; Wang ZX; Rincon F; Tjoumakaris SI; Jabbour P; Rosenwasser RH; Gooch MR
    J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):846-848. PubMed ID: 32354770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
    Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
    Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody therapy in COVID-19.
    Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease.
    Domingues RB; Mendes-Correa MC; de Moura Leite FBV; Sabino EC; Salarini DZ; Claro I; Santos DW; de Jesus JG; Ferreira NE; Romano CM; Soares CAS
    J Neurol; 2020 Nov; 267(11):3154-3156. PubMed ID: 32564153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
    Petrone L; Petruccioli E; Vanini V; Cuzzi G; Najafi Fard S; Alonzi T; Castilletti C; Palmieri F; Gualano G; Vittozzi P; Nicastri E; Lepore L; Antinori A; Vergori A; Caccamo N; Cantini F; Girardi E; Ippolito G; Grifoni A; Goletti D
    Clin Microbiol Infect; 2021 Feb; 27(2):286.e7-286.e13. PubMed ID: 33045370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
    Venkataraman A; Kumar NP; Hanna LE; Putlibai S; Karthick M; Rajamanikam A; Sadasivam K; Sundaram B; Babu S
    EBioMedicine; 2021 Apr; 66():103317. PubMed ID: 33813138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.
    Heming M; Li X; Räuber S; Mausberg AK; Börsch AL; Hartlehnert M; Singhal A; Lu IN; Fleischer M; Szepanowski F; Witzke O; Brenner T; Dittmer U; Yosef N; Kleinschnitz C; Wiendl H; Stettner M; Meyer Zu Hörste G
    Immunity; 2021 Jan; 54(1):164-175.e6. PubMed ID: 33382973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients.
    van Riel D; Embregts CWE; Sips GJ; van den Akker JPC; Endeman H; van Nood E; Raadsen M; Bauer L; van Kampen J; Molenkamp R; Koopmans M; van de Vijver D; GeurtsvanKessel CH
    mSphere; 2021 Jun; 6(3):e0031121. PubMed ID: 34047654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
    Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.